TOYIN ADEKUNLE: Open Payments
NPI 1063073153 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$139 in 6 payments from 4 companies in 2025. Trend: 2023 $28 · 2024 $340 · 2025 $139
Food & beverage: $139
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
Products named: INVEGA SUSTENNA, INGREZZA, UZEDY, REXULTI, AUSTEDO XR, ABILIFY MAINTENA.
Industry payments across GA — which companies pay providers there.
